COVID-19 Research

March 26, 2020

No items found.

‍Research funding opportunities related to COVID-19

On behalf of the Department of Health and Social Care, NIHR has established a single national process to prioritise and coordinate funding for COVID-19 research. This applies across all funded studies including public sector, industry and charity funding.

Information about this can be found here

Details of the process and the new single entry point can be found here

Application form is here

‍

UKRI Open Call – Research and innovation ideas to address COVID-19

IMI2 - Call 21 Development of therapuetics and diagnostics combatting coronavirus infections (closes 31 March 2020)

DASA COVID-19 Rapid sanitising technology for ambulances (closes 1st April 2020)

‍TechForce19 Supporting the elderley, vulnerable and self-isolating during COVID-19 (closes 1 April 2000)

LifeArc COVID-19 Development and testing of therapeutics (closes 6th April 2020)

Innovate UK Business-led innovation in response to global disruption (de minimis) (closes 17 April)

BSAC COVID-19 Supporting research projects (closes 17 April, simple application)

COVID-19 Therapeutics Accelerator Bill & Melinda Gates Foundation, Mastercard, Wellcome - contact: epidemics@wellcome.ac.uk for more infomation

Wellcome: Epidemic Preparedness COVID-19 (reviewing current proposals, may reopen)

‍

Are you researching COVID-19?

We love what all of our clients do. And we're always impressed by those working to tackle health care problems and save lives

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

We can also offer support with:

Identifying appropriate government support for your business
Bringing your year end forward so that you can file your R&D Tax Claim sooner
Free 1-2-1 support via the Innovate2succeed Programme
Plus a comprehensive range of other business support services
‍

‍Business Support Information

We've collated this list of links for businesses during this time

‍

We're here for an informal chat if you want to talk any of this through - just contact us using the details below

Call us on 01925 506100
Email us at info@inventya.com

Thanks for all that you're doing

‍

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML

Downloaded from here cropped to size

‍

March 26, 2020

← back to news

Consultancy

Bid Writing

Thank you! We will be in touch shortly.

Oops! Something went wrong while submitting the form.

Your privacy matters | View our privacy policy

More of our news

Inventya Ltd Recognised in FT1000: Europe’s Fastest Growing Companies 2025

Inventya Ltd is proud to announce that we have been featured in the Financial Times’ ninth annual FT1000: Europe’s Fastest Growing Companies 2025 list. This prestigious ranking, compiled in collaboration with Statista, recognizes the top 1,000 European companies that have demonstrated exceptional revenue growth and resilience over the past years.

March 5, 2025

Invitation to Tender: Business Data and Insights Platform

Inventya requires access to an online database or market intelligence platform for discovering, tracking and understanding high growth UK businesses. This contract is for 96 licenses and will include training and support services.

January 23, 2025

Preparing to Scaleup-Key Focus Areas

Scaling isn’t just about rapid growth, it’s about sustainable growth. While high growth often signals momentum, scaling requires systems, processes, and resources that can keep pace with expansion. Before making the leap, assess key metrics like consistent revenue growth, customer retention, and strong unit economics. Beyond numbers, evaluate whether your team and operational processes are efficient and scalable.

January 14, 2025

Inventya Partners in the AIRCARE Project - An EU Funded Project for Robotic and AI Cancer Diagnosis and Treatment

The AIRCARE Project, a European initiative funded under the Horizon Europe Programme, has secured almost eight million euros to transform the diagnosis and treatment of Upper Aerodigestive Tract (UADT) cancers. Coordinated by the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology), AIRCARE brings together leading research institutions, hospitals, and industry experts across Europe. The project aims to introduce advanced AI-driven and robotic technologies into clinical workflows, offering new standards of care in the detection, diagnosis, and treatment of UADT cancers.

December 19, 2024

Inventya Recognized as Fastsest Growing Professional Services Firm in the North by the as in UK Fast Growth Index 2024

Inventyais proud to be recognised as the fastestgrowing professional service firm in the north of England inthe UK Fast Growth Index 2024, which recognises the nation's most rapidlyexpanding and innovative businesses. This award recognises our commitment toexcellence and significant contributions to the UK's economic landscape.

December 2, 2024

How SMEs Can Leverage the UK Government’s Sustainability Agenda for Growth

The UK government’s renewed focus on sustainability presents SMEs with an unprecedented opportunity to grow and thrive. From access to capital and job creation to simplified regulations and consumer demand for eco-friendly products, there are numerous ways SMEs can benefit from the government’s sustainability agenda.

September 11, 2024

COVID-19 Research

March 26, 2020

‍Research funding opportunities related to COVID-19

Are you researching COVID-19?

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML

Downloaded from here cropped to size

More of our news

The latest funding, scale up and business growth tips, straight to your inbox

Commercial Services

Innovate UK Business Growth (previously Innovate UK EDGE)

Contact

Social Links

Other

COVID-19 Research

March 26, 2020

‍Research funding opportunities related to COVID-19

Are you researching COVID-19?

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab. Credit: NIAID-RML

Downloaded from here cropped to size

More of our news

The latest funding, scale up and business growth tips, straight to your inbox

Commercial Services

Innovate UK Business Growth (previously Innovate UK EDGE)

Contact

Social Links

Other

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML